ExodusPoint Capital Management, LP - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 91 filers reported holding SURFACE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q1 2022$57,000
+16.3%
19,344
+88.4%
0.00%0.0%
Q4 2021$49,000
-53.8%
10,267
-26.4%
0.00%0.0%
Q3 2021$106,000
-56.4%
13,944
-57.2%
0.00%
-66.7%
Q2 2021$243,000
-71.8%
32,544
-70.5%
0.00%
-76.9%
Q1 2021$862,000
+326.7%
110,498
+404.4%
0.01%
+550.0%
Q4 2020$202,00021,9070.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders